Cell Mates

What actually makes automation “stick” in cell therapy manufacturing? Is it the tech… or the trust? In Episode 4 of Cell Mates, Fred sits down with Mary-Ann Santos from Thermo Fisher Scientific to unpack the real adoption flywheel: belief, fear, data, and the moment everything clicks when you see a robot run a process with your own eyes. They go deep on why modular automation scales faster than “a...

What is a collaborative robot, and what makes it special? Why does this characteristic make it suitable for the pharma space? In Episode 3 of Cell Mates, we explore how collaborative robotics could redefine manufacturing models, shift the role of human experts, and unlock entirely new possibilities in biomanufacturing. Highlights include: What other industries can teach pharma about robotic adopti...

What tasks are humanoids uniquely good at and what does that mean for the future of work? In Episode 2 of Cell Mates, we invite Tony Yang, Director of North American Markets from Unitree Robotics to discuss the future of humanoid robots and how robots can fundamentally change the future. We explore in particular what this means for the biomanufacturing industry. Highlights include: Where do humano...

What happens when scientists and engineers collaborate to tackle the biggest challenges in pharma manufacturing? In this debut episode, Multiply Labs CEO Frederico Parietti, Ph. D., sits down with Sanket Acharya, Ph. D., Senior Director of Corporate Development at GenScript, to explore the critical intersection of science and automation. Key topics we cover: ⚙️ What engineers often misunderstand a...

What’s the biggest difference between how scientists and engineers think? 🤔 What happens when you put scientists and engineers in the same room to brainstorm solutions to some of pharma’s biggest challenges?  Multiply Labs explores these very questions and more in their NEW podcast: Cell Mates, the podcast that is building the future of pharma automation, one conversation at a time!  🎧You won’t...